Nicole Leber | Investor Relations |
Panna Sharma | President and CEO |
David Margrave | Chief Financial Officer |
Kishor Bhatia | Chief Scientific Officer |
Michael King | H.C. Wainwright |
Kyle Bauser | Colliers Int’l. Securities |
Good afternoon, everybody. And welcome to the Lantern Pharma Fourth Quarter and Fiscal Year 2021 Earnings Call.
As a reminder, this call is being recorded and all the attendees are in a listen-only mode.
We will open the call for questions-and-answers after management’s presentation. I am Nicole Leber with Investor Relations at Lantern Pharma and I will be your host for today’s call.